Carnitine-acylcarnitine translocase deficiency: identification of a novel molecular defect in a Bedouin patient
- PMID: 15159657
- DOI: 10.1023/B:BOLI.0000028780.01670.61
Carnitine-acylcarnitine translocase deficiency: identification of a novel molecular defect in a Bedouin patient
Abstract
Carnitine-acylcarnitine translocase CACT deficiency is a very rare autosomal recessive disease. The neonatal phenotype of CACT deficiency is characterized by hypoketotic hypoglycaemia, hyperammonaemia, cardiomyopathy and skeletal muscle weakness culminating in early death. The disease is caused by mutations in the CACT gene, which encodes a protein transporting long-chain fatty acid carnitine esters into the mitochondrial matrix. In this report, we describe the first case of CACT deficiency in the Bedouin population in Israel. The patient, the first son of consanguineous parents, was born at term after uneventful delivery. During the second day of life, he developed clinical signs of an acute metabolic crisis with severe hypoglycaemia and hyperammonaemia. Biochemical investigation suggested the diagnosis of CACT deficiency. Genetic molecular analysis confirmed this diagnosis by demonstrating that the affected child was homozygous for a novel missense mutation 793A>G, substituting glutamine by arginine (Q238R) in exon 7 of the CACT gene. Despite medical treatment and adequate nutrition, the patient died at 6 months of age.
Similar articles
-
Molecular and functional analysis of SLC25A20 mutations causing carnitine-acylcarnitine translocase deficiency.Hum Mutat. 2004 Oct;24(4):312-20. doi: 10.1002/humu.20085. Hum Mutat. 2004. PMID: 15365988
-
Prospective treatment in carnitine-acylcarnitine translocase deficiency.J Inherit Metab Dis. 2007 Oct;30(5):815. doi: 10.1007/s10545-007-0518-x. Epub 2007 May 12. J Inherit Metab Dis. 2007. PMID: 17508264
-
Carnitine-acylcarnitine translocase deficiency, clinical, biochemical and genetic aspects.Mol Aspects Med. 2004 Oct-Dec;25(5-6):521-32. doi: 10.1016/j.mam.2004.06.007. Mol Aspects Med. 2004. PMID: 15363639 Review.
-
Carnitine-acylcarnitine translocase deficiency: Two neonatal cases with common splicing mutation and in vitro bezafibrate response.Brain Dev. 2015 Aug;37(7):698-703. doi: 10.1016/j.braindev.2014.10.005. Epub 2014 Nov 1. Brain Dev. 2015. PMID: 25459972
-
Carnitine-acylcarnitine translocase deficiency: case report and review of the literature.Acta Paediatr. 2003 Apr;92(4):501-4. doi: 10.1111/j.1651-2227.2003.tb00586.x. Acta Paediatr. 2003. PMID: 12801121 Review.
Cited by
-
Carnitine-acylcarnitine translocase deficiency: experience with four cases in Spain and review of the literature.JIMD Rep. 2015;20:11-20. doi: 10.1007/8904_2014_382. Epub 2015 Jan 23. JIMD Rep. 2015. PMID: 25614308 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical